IDEXX Laboratories
IDXX
$476.35
Share price
-0.30%
Change (1 day)
-1.20%
Change (1 year)
Categories
IDEXX Laboratories (IDXX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.77 B
According to IDEXX Laboratories's latest financial reports the company's total liabilities are $1.77 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
IDEXX Laboratories - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.77 B | -16.96% |
| 2022-12-31 | $2.13 B | 22.37% |
| 2021-12-31 | $1.74 B | 5.14% |
| 2020-12-31 | $1.66 B | 0.43% |
| 2019-12-31 | $1.65 B | 6.99% |
| 2018-12-31 | $1.54 B | -12.49% |
| 2017-12-31 | $1.76 B | 7.83% |
| 2016-12-31 | $1.63 B | 5.13% |
| 2015-12-31 | $1.55 B | 23.08% |
| 2014-12-31 | $1.26 B | 77.82% |
| 2013-12-31 | $0.71 B | 52.41% |
| 2012-12-31 | $0.46 B | -4.86% |
| 2011-12-31 | $0.49 B | 52.15% |
| 2010-12-31 | $0.32 B | 9.84% |
| 2009-12-31 | $0.29 B | -10.17% |
| 2008-12-31 | $0.32 B | 24.02% |
| 2007-12-31 | $0.26 B | 76.26% |
| 2006-12-31 | $0.14 B | 23.35% |
| 2005-12-31 | $0.12 B | 4.46% |
| 2004-12-31 | $0.11 B | 7% |
| 2003-12-31 | $0.10 B | 42.03% |
| 2002-12-31 | $76.45 M | 7.11% |
| 2001-12-31 | $71.37 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $34.38 B | 1,836.87% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $51.88 B | 2,822.40% | 🇺🇸 USA |
 Henry Schein
HSIC | $5.42 B | 205.29% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $95.03 M | -94.65% | 🇺🇸 USA |
 Neogen NEOG | $1.45 B | -18.05% | 🇺🇸 USA |
 Heska Corporation
HSKA | $0.17 B | -90.14% | 🇺🇸 USA |
 Petco WOOF | $4.23 B | 138.47% | 🇺🇸 USA |